Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alessandra DiBacco"'
Autor:
Jan-Rung Mo, Anjili Mathur, Minilik Angagaw, Shuxia Zhao, Yuxun Wang, Diana Gargano, Alessandra DiBacco, Eric S Bachman
Publikováno v:
PLoS ONE, Vol 4, Iss 9, p e7286 (2009)
Splenic enlargement (splenomegaly) develops in numerous disease states, although a specific pathogenic role for the spleen has rarely been described. In polycythemia vera (PV), an activating mutation in Janus kinase 2 (JAK2(V617)) induces splenomegal
Externí odkaz:
https://doaj.org/article/710f5ab188684f0988a70f6dc513a604
Autor:
Philippe Moreau, Ludek Pour, Jacob P. Laubach, Peter Gimsing, Ai-Min Hui, Markus Hansson, Jianchang Lin, Nizar J. Bahlis, Francis K. Buadi, D. Simpson, Tamas Masszi, Michele Cavo, Irwindeep Sandhu, Peter Ganly, Deborah Berg, Cyrille Touzeau, Shaji Kumar, Paul G. Richardson, Sharon Jackson, Bartrum W Baker, Norbert Grzasko, Laurent Garderet, Alessandra DiBacco, Antonio Palumbo, Anne-Marie Stoppa
Publikováno v:
Blood. 126:727-727
Background Ixazomib is the first orally administered PI studied in the clinic. The feasibility of combining ixazomib weekly and lenalidomide-dexamethasone (Rd) in the first all-oral PI- and immunomodulatory drug-containing triplet regimen was evaluat
Autor:
Shuhei Sakakibara, Adam Rosendorff, Yang Shi, Grace Gill, Alessandra DiBacco, Sixin Lu, Yan Xuan, Elliott Kieff, Yujiang Shi
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 103(14)
Small ubiquitin-like modifier (SUMO) modification of transcription factors is generally associated with repression. Reverse genetic analysis of SUMO-1, and -2 conserved residues emphasized the importance of dual charge reversals in abrogating the cri
Autor:
Diana Gargano, Jan-Rung Mo, Anjili Mathur, Shuxia Zhao, Eric Bachman, Alessandra DiBacco, Minilik Angagaw, Yuxun Wang
Publikováno v:
PLoS ONE, Vol 4, Iss 9, p e7286 (2009)
PLoS ONE
PLoS ONE
Splenic enlargement (splenomegaly) develops in numerous disease states, although a specific pathogenic role for the spleen has rarely been described. In polycythemia vera (PV), an activating mutation in Janus kinase 2 (JAK2(V617)) induces splenomegal